Conscious Chemist Announces INR 12 Cr Funding from Atomic Capital; Welcomes Apoorv Gautam to the Board

Conscious Chemist has raised INR 12 Cr. funding from Atomic Capital. The brand has appointed Apoorv Gautam, Atomic Capital’s Founder and Managing Partner, to its board of directors.  

READ MORE

SLB Announces Third-Quarter 2024 Results Conference Call

Houston, United States:   SLB (NYSE: SLB) will hold a conference call on October 18, 2024, to discuss the results for

READ MORE

Noble Corporation plc announces changes to its share capital including share repurchases for the month of September 2024

SUGAR LAND, TEXAS, September 30, 2024 /PRNewswire/ – Noble Corporation plc (“Noble”) (CSE: NOBLE, NYSE: NE) today announces changes to

READ MORE

Lundin Mining Announces Updated Share Capital and Voting Rights

VANCOUVER, BC, Sept. 30, 2024 /CNW/ – (TSX: LUN; Nasdaq Stockholm: LUMI) Lundin Mining Corporation (“Lundin Mining” or the “Company”)

READ MORE

Vestas announces three orders, amounting to 113 MW in total

News release from Vestas Wind Systems A/S Aarhus, 30 September, 2024   Vestas is proud to announce the following orders as

READ MORE

DHL Express Announces Annual Price Adjustments for 2025 in India

DHL Express, the world’s leading international express services provider, announced price adjustments today that will take effect on January 1, 2025. The average increase

READ MORE

Malabar Group Announces Scholarships for Over 21,000 Girl Students, Reinforces its Vision for Women Empowerment

Malabar Group, a leading diversified Indian business conglomerate – the parent company of Malabar Gold & Diamonds, announced its National Scholarship Programme for 2024

READ MORE

New York Life Investments Announces Changes to ETF Lineup

New York, United States:   New York Life Investments today announced plans to liquidate the following ETFs (the “Funds”) as part

READ MORE

Storskogen announces results from the partial tender offer

Storskogen Group AB (publ) (“Storskogen”) announces the results of the partial tender offer (the “Tender Offer”) to the holders of Storskogen’s

READ MORE

Cereno Scientific announces positive topline results of Phase IIa trial with lead candidate CS1 in Pulmonary Arterial Hypertension

Primary endpoint of safety and tolerability met successfully Positive impact on exploratory clinical efficacy parameters: REVEAL risk score: 43% (9/21) of

READ MORE